The Protein Tyrosine Phosphatase CD45 promotes PMN Transepithelial Migration, Antimicrobial Function and Colonic Mucosal Repair

This study demonstrates that the protein tyrosine phosphatase CD45 is essential for regulating polymorphonuclear neutrophil (PMN) trafficking, antimicrobial functions, and colonic mucosal repair through a CD11b-Lyn signaling axis, suggesting its potential as a therapeutic target for modulating PMN activity in inflammatory bowel disease.

The Gist

The Big Picture: The Body's "Repair Crew" and Their Missing Tool

Imagine your body is a bustling city, and your gut (intestine) is a busy highway. Sometimes, this highway gets damaged by bad bacteria or irritants (like a car crash or a pothole).

To fix this, the body sends in a specialized repair crew: the Neutrophils (or PMNs). These are the first responders. Their job is twofold:

1. Clean up: Eat the bad bacteria (like Pac-Man eating ghosts).
2. Fix the road: Help the tissue heal so the highway is safe again.

However, if too many repair crews show up, or if they get confused and stay too long, they can cause a traffic jam that turns into a chronic disaster (like Inflammatory Bowel Disease). The body needs a way to control these crews perfectly: send them when needed, activate them to do their job, and then let them leave once the work is done.

The Discovery: The "Foreman" (CD45)

This paper discovered a specific protein called CD45. Think of CD45 as the Foreman or the Site Manager for the Neutrophil repair crew.

For a long time, scientists thought this Foreman only managed the "Special Forces" (T and B cells) of the immune system. But this study found out that the Foreman is actually critical for the Neutrophil repair crew too. Without the Foreman, the crew gets confused, lazy, and ineffective.

What Happens When the Foreman is Gone?

The researchers ran experiments to see what happens when they remove or "turn off" this Foreman (CD45) in the gut. Here is what they found, using simple analogies:

1. The Crew Can't Get to the Job Site (Migration)

• The Science: Neutrophils couldn't move across the gut lining to get to the injury.
• The Analogy: Imagine the repair crew is stuck in the parking lot because the gate is locked. They can't get onto the highway to fix the pothole. The study showed that without CD45, the "gate" (the cell's ability to move) stays shut.

2. The Crew is Lazy and Clumsy (Effector Functions)

• The Science: The neutrophils couldn't eat bacteria (phagocytosis) or release their "weapons" (degranulation) effectively.
• The Analogy: Even if the crew somehow got to the site, they were asleep at the wheel. They dropped their tools, couldn't grab the bad bacteria, and couldn't spray the necessary cleaning chemicals. They were physically present but useless.

3. The Road Never Gets Fixed (Healing)

• The Science: Mice without this Foreman took much longer to heal from colitis (gut inflammation) and physical wounds.
• The Analogy: Because the crew was stuck in the parking lot and too lazy to work, the pothole on the highway never got filled. The road remained broken, leading to more traffic jams (inflammation) and danger.

How Does the Foreman Do It? (The Mechanism)

The researchers figured out how CD45 manages the crew. They found a specific chain of command:

1. The "On" Switch (Lyn Kinase): Inside the neutrophil, there is a protein called Lyn. Think of Lyn as the Engine of the repair truck.
2. The Brake Pedal: Usually, there is a "brake" on the engine (a chemical tag called phosphorylation) that keeps the engine from revving too high.
3. The Foreman's Job: CD45's job is to cut the brake line. It removes that tag, allowing the engine (Lyn) to start running.
4. The Result: When the engine runs, it turns on the Integrins (CD11b/CD18). Think of Integrins as the Tires and Grips of the truck.
   • With good tires (active Integrins), the truck can grip the road and drive to the site.
   • With good tires, the truck can also hold onto the bad bacteria and crush them.

Without CD45: The brake stays on. The engine (Lyn) is stuck. The tires (Integrins) are flat. The truck (Neutrophil) can't move, can't grab anything, and can't fix the road.

Why Does This Matter?

This is a big deal for two reasons:

1. Understanding Disease: It explains why some people get stuck in a cycle of gut inflammation (like Crohn's disease or Ulcerative Colitis). Their repair crews might be malfunctioning because this "Foreman" isn't doing its job right.
2. New Treatments: Scientists can now look for drugs that tweak this Foreman.
   • If the gut is inflamed too much, maybe we can temporarily slow the Foreman down to stop the traffic jam.
   • If the gut is damaged and won't heal (like in chronic wounds), maybe we can boost the Foreman to wake up the repair crew and get the job done.

Summary

This paper tells us that CD45 is a vital manager for the body's first-responder cells in the gut. It acts like a master switch that turns on the engine and inflates the tires of the repair trucks. Without it, the gut stays damaged, infections linger, and inflammation never goes away. Understanding this switch opens the door to new medicines that can help heal the gut faster and stop chronic pain.

Technical Summary

1. Problem Statement

Polymorphonuclear neutrophils (PMNs) are critical for clearing pathogens and initiating tissue repair in mucosal tissues like the intestine. However, their functions are a double-edged sword: while essential for defense, excessive or dysregulated PMN migration (transepithelial migration or TEpM) drives chronic inflammatory disorders such as Inflammatory Bowel Disease (IBD). Conversely, insufficient PMN function leads to chronic infection and delayed healing.

The molecular signaling cascades regulating PMN trafficking and effector functions (such as phagocytosis and degranulation) in the gut are incompletely understood. While the protein tyrosine phosphatase CD45 (PTPRC) is well-characterized as a regulator of adaptive immunity (T and B cells), its specific role in innate PMN responses within the intestinal mucosa remains largely unexplored. This study aims to define the role of CD45 in regulating PMN trafficking, antimicrobial functions, and mucosal repair in the gut.

2. Methodology

The researchers employed a multi-faceted approach combining in vitro models, pharmacological inhibition, genetic engineering, and in vivo murine models:

• Pharmacological Inhibition: Human and murine PMNs were treated with CD45 inhibitor VI (an irreversible allosteric inhibitor) or an anti-CD45 monoclonal antibody (MEM-28) to assess acute effects on function.
• In Vitro Migration Models:
  • T84 Cell Monolayers: Standard model for PMN transepithelial migration (TEpM).
  • Primary Human Colonoids: Novel model using inverted monolayers of primary human colonic epithelial cells to mimic physiological barriers more accurately.
• Genetic Models:
  • CRISPR/Cas9 Knockout: Generation of CD45-deficient HL60 cells (human promyelocytic leukemia cells differentiated into PMN-like phenotypes).
  • Conditional Knockout Mice: Creation of MRP8-Cre;Cd45fl/fl mice, which specifically delete CD45 in granulocytes (PMNs) while sparing adaptive immune cells (T/B cells) and other innate cells (monocytes, eosinophils). This avoids the confounding immunodeficiencies seen in global CD45 knockouts.
• Functional Assays:
  • TEpM: Quantified via Myeloperoxidase (MPO) assay and flow cytometry.
  • Degranulation: Measured by surface expression of primary (CD63) and secondary (CD66b/CD15) granule markers.
  • Phagocytosis: Quantified via uptake of fluorescent FluoSpheres.
  • Signaling Analysis: Western blotting for Src Family Kinases (SFKs: Hck, Fgr, Lyn) and their phosphorylation states (specifically inhibitory Tyr507). Flow cytometry for CD11b/CD18 surface expression and activation.
• In Vivo Models:
  • DSS-Induced Colitis: To assess recovery from chemical injury.
  • Biopsy-Induced Wounding: To assess mechanical wound healing in the colon.
  • Colonic Loop Model: To quantify PMN recruitment to the intestinal lumen in response to chemoattractants (LTB4).

3. Key Contributions

• Novel Role of CD45 in Innate Immunity: Establishes CD45 as a critical positive regulator of PMN function in the intestine, distinct from its known role in adaptive immunity.
• PMN-Specific Genetic Model: Successfully generated and validated the first PMN-specific CD45 knockout mouse model (MRP8-Cre;Cd45fl/fl), allowing for the isolation of PMN-specific effects without adaptive immune interference.
• Identification of a New Signaling Axis: Discovered a specific CD45–CD11b–Lyn signaling axis that governs PMN trafficking and effector functions.
• Mechanistic Insight: Demonstrated that CD45 is required for the dephosphorylation (activation) of the Src family kinase Lyn, which in turn stabilizes CD11b/CD18 integrin expression and activation.

4. Key Results

A. CD45 Regulates PMN Transepithelial Migration (TEpM)

• Inhibition: Pharmacological inhibition of CD45 (using CD45 inhibitor VI or anti-CD45 mAb) reduced PMN migration across both T84 and primary human colonoid monolayers by >50–60%.
• In Vivo: Inhibition of CD45 reduced PMN recruitment to the colonic lumen in a surgical loop model.
• Genetic Depletion: MRP8-Cre;Cd45fl/fl mice showed a significant reduction in PMN trafficking to the intestine compared to controls.

B. CD45 is Essential for Antimicrobial Effector Functions

• Degranulation: CD45 inhibition or depletion significantly reduced the surface expression of granule markers (CD63, CD66b, CD15) in response to fMLF/Latrunculin B stimulation in both human and murine PMNs.
• Phagocytosis: CD45-deficient PMNs (inhibitor-treated, KO HL60s, and MRP8-Cre;Cd45fl/fl) exhibited significantly reduced uptake of fluorescent beads, indicating impaired pathogen clearance capabilities.

C. Impact on Mucosal Repair

• DSS Colitis: MRP8-Cre;Cd45fl/fl mice exhibited delayed recovery from DSS-induced colitis, characterized by higher disease activity scores (weight loss, diarrhea, bleeding) and increased histological inflammation/ulceration compared to controls.
• Wound Healing: In a biopsy-induced wounding model, mice with PMN-specific CD45 depletion showed significantly delayed mucosal wound closure at 24 and 72 hours.

D. Mechanistic Pathway: CD45 → Lyn → CD11b/CD18

• Integrin Regulation: CD45 inhibition or depletion led to reduced surface expression and reduced activation (conformational change) of the β2-integrin CD11b/CD18, a key molecule for adhesion and migration.
• Kinase Regulation: Western blotting revealed that in the absence of CD45, the Src family kinase Lyn remained hyper-phosphorylated at the inhibitory Tyr507 residue.
  • CD45 normally dephosphorylates Tyr507 to activate Lyn.
  • Without CD45, Lyn remains inactive.
  • This inactivation of Lyn correlates with the downregulation of CD11b/CD18.
• Specificity: This effect was specific to Lyn; phosphorylation of other PMN SFKs (Hck and Fgr) was unaffected by CD45 depletion.

5. Significance

This study fundamentally shifts the understanding of CD45 from a lymphocyte-centric regulator to a critical modulator of neutrophil plasticity in mucosal tissues.

• Therapeutic Implications: The findings suggest that while global CD45 inhibition might be considered for autoimmune diseases, it could be detrimental in contexts requiring mucosal healing (like IBD flares) because it impairs the very PMN functions needed for tissue repair and pathogen clearance. Conversely, strategies to enhance CD45-mediated signaling in specific contexts could promote mucosal repair.
• Mechanistic Clarity: The identification of the CD45-Lyn-CD11b axis provides a concrete molecular target for modulating neutrophil behavior. It explains how phosphatase activity directly influences integrin-mediated adhesion and migration.
• Model Validation: The successful generation of the PMN-specific CD45 knockout mouse resolves previous ambiguities regarding global CD45 knockouts, where adaptive immune defects often confounded the interpretation of innate immune data.

In conclusion, CD45 is a "master switch" that positively regulates PMN trafficking, antimicrobial activity, and mucosal repair in the gut via the dephosphorylation of Lyn kinase and subsequent stabilization of CD11b/CD18 integrins.